Skip to main content

Day: March 30, 2022

Osisko Development Intersects 9.05 g/t Au Over 11.65 Meters Including 73.0 g/t Au Over 0.75 Meter at Lowhee

Figure 1: Cariboo deposit areas overview map Figure 1: Cariboo deposit areas overview mapFigure 2: Lowhee Zone select drilling highlights Figure 2: Lowhee Zone select drilling highlightsMONTREAL, March 30, 2022 (GLOBE NEWSWIRE) — Osisko Development Corp. (“Osisko Development” or the “Company”) (TSX.V-ODV) is pleased to announce drilling results from the 2021 exploration and category conversion drill campaign at its Cariboo Gold Project (“Cariboo”) in central British Columbia. SummaryA total of 29,450 meters were drilled in 94 holes at Lowhee Zone on Barkerville Mountain in 2021. Final assay results have now been received and this release include holes BM-21-081 to BM-21-094 (Figures 1 and 2). Drillhole BM-21-082 intersected multiple high-grade samples including 38.10 g/t Au over 0.50 meter, 70.00 g/t Au over 0.50 meter...

Continue reading

Anaergia Inc. Announces $60 Million Bought Deal Offering of Subordinate Voting Shares

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ BURLINGTON, Ontario, March 30, 2022 (GLOBE NEWSWIRE) — Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) today announced that it has entered into an agreement to sell, on a bought deal basis, 4,800,000 subordinate voting shares (the “Shares”) at a price of $12.50 per Share (the “Issue Price”) to a syndicate of underwriters led by TD Securities Inc. (the “Underwriters”) for gross proceeds of approximately $60 million (the “Offering”). In addition, the Company has granted the Underwriters an over-allotment option (the “Over-Allotment Option”) to purchase up to an additional 720,000 Shares at the Issue Price, exercisable, in whole or in part, for a period of 30 days following closing of the Offering. If the Over-Allotment Option is exercised...

Continue reading

DT Midstream Announces Pricing of Private Offering of Senior Secured Notes

DETROIT, March 30, 2022 (GLOBE NEWSWIRE) — DT Midstream, Inc. (“DT Midstream” or the “Company”) (NYSE: DTM) today announced that it has priced an offering (the “Offering”) of $600,000,000 of 4.300% Senior Secured Notes due 2032 (the “Notes”). The Notes will be issued by DT Midstream, guaranteed by certain of DT Midstream’s subsidiaries and secured by a first priority lien on certain assets of DT Midstream and its subsidiary guarantors that secure DT Midstream’s existing credit facilities. The Offering is expected to close on April 11, 2022, subject to customary closing conditions. DT Midstream intends to use the net proceeds from the sale of the Notes to partially repay existing indebtedness under its term loan facility and expects the transaction to be leverage-neutral. The Notes are being sold in a private placement to persons...

Continue reading

Precision Drilling Announces Filing of Management Information Circular and Virtual-Only Annual and Special Meeting of Shareholders

This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For important information with respect to such forward-looking information and statements and the further assumptions and risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release. CALGARY, Alberta, March 30, 2022 (GLOBE NEWSWIRE) — Precision Drilling Corporation (“Precision” or the “Company”) (TSX:PD; NYSE:PDS) announces today the filing and publication of its Management Information Circular (the “Circular”) issued in connection with the 2022 Annual and Special Meeting of Shareholders (the “Annual Meeting”). Management Information Circular & Virtual-Only Annual Meeting Details Precision announces...

Continue reading

Nocopi Reports 2021 Revenue of $1.95M, Operating Cash Flow of $0.51M, Net Income of $0.05M and Year-End Cash Position of $1.85M

KING OF PRUSSIA, Pa., March 30, 2022 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its fourth quarter and year ended December 31, 2021 (Q4 ’21 and FY 2021). Nocopi’s SEC filings are available here. 2021 SummaryTotal revenue declined approximately 27% to $1.95M as global supply chain disruptions, including port congestion and container shortages, affected purchases of ink by Asia-based printers, primarily in the second half of the year. Revenue from licenses and royalties increased nearly 9% to $809,900 driven by a key client in the toy and entertainment sector. Cash increased to $1.85M at year-end 2021 versus $1.36M...

Continue reading

Aerovate Therapeutics Announces Full-Year 2021 Financial Results

Initiated IMPAHCT, a global Phase 2b/Phase 3 trial of AV-101 for pulmonary arterial hypertension (PAH) in December 2021 Received FDA guidance in April 2021 that our Phase 2b/Phase 3 trial could support an NDA submission based on change in six minute walk distance as the primary endpoint for the Phase 3 portion of the trial Granted orphan drug designation by the FDA in December 2020 and EMA for AV-101 for the treatment of PAH in June 2021 Raised $126.9 million in net proceeds from IPO in July 2021WALTHAM, Mass., March 30, 2022 (GLOBE NEWSWIRE) —  Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the year ended December 31, 2021, and recent business...

Continue reading

LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Phase 3 registrational trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) ongoing Mavacamten granted breakthrough therapy designation in China for the treatment of patients with oHCM Infigratinib approved under special named patient program for the treatment of cholangiocarcinoma (CCA) in the Bo’Ao pilot zone of Hainan Province in China Three additional pipeline programs expected to enter into registrational Phase 3 clinical trials in China by year-end 2022 Cash balance of $403.2 million with runway through 2023 SHANGHAI and PRINCETON, N.J., March 30, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today reported financial results for the fourth quarter...

Continue reading

MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference

NEWS RELEASEMarch 30, 2022, 4:30 PM EST / 22:30 CET MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference IRVINE, CA, and HERSTAL, BELGIUM – March 30, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, CEO, will participate in the 14th Annual Kempen Life Sciences Conference which will take place in Amsterdam on April 20, 2022. The Company will be available for 1×1 meetings and invites investors to contact their Kempen representative for further information.2022 Updated Reporting CalendarApril 27, 2022: Q1-2022 business update May 25, 2022: Annual general shareholders’ meeting August 25, 2022: Publication of H1-2022 results October 27, 2022: Q3-2022 business updateAbout MDxHealth MDxHealth is a commercial-stage precision...

Continue reading

CORRECTION – Duke Realty Corporation Schedules First Quarter 2022 Earnings Release and Conference Call

INDIANAPOLIS, March 30, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Duke Realty Corporation (NYSE: DRE) please note that in the first paragraph of the release, the call date should be “Thursday, April 28th” rather than “Thursday, May 28th.” The corrected release follows: Duke Realty Corporation (NYSE: DRE) today announced that the company will release its first quarter 2022 operating results on Wednesday, April 27th, after the market close. The company will host its quarterly earnings conference call on Thursday, April 28th, at 12:00 p.m. Eastern Time. The public may access the conference call through a live audio webcast available on the investor relations section of Duke Realty’s website at www.dukerealty.com. Supplemental materials will be posted to the investor...

Continue reading

Kornit Digital Announces Filing and Availability of Its Annual Report on Form 20-F

ROSH HA’AYIN, Israel, March 30, 2022 (GLOBE NEWSWIRE) — Kornit Digital LTD. (NASDAQ: KRNT) (“Kornit”), a worldwide market leader in sustainable, on-demand digital fashionx and textile production, announced today that its annual report on Form 20-F, containing audited consolidated financial statements for the year ended December 31, 2021, as filed with the Securities and Exchange Commission, is available through its website (http://www.kornit.com). Shareholders may receive a hard copy of the annual report free of charge upon request. This press release is being issued pursuant to NASDAQ Listing Rule 5250(d)(1)(C). About Kornit Digital Kornit Digital (NASDAQ: KRNT) is a worldwide market leader in sustainable, on-demand, digital fashionx and textile production technologies. The company is writing the operating system for fashion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.